Highline Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.1K | Sell |
4
-5
| -56% | -$2.63K | ﹤0.01% | 636 |
|
|
2025
Q1 | $5.71K | Buy |
9
+3
| +50% | +$1.9K | ﹤0.01% | 399 |
|
|
2024
Q4 | $4.27K | Buy |
6
+3
| +100% | +$2.14K | ﹤0.01% | 366 |
|
|
2024
Q3 | $3.15K | Buy |
3
+1
| +50% | +$1.05K | ﹤0.01% | 404 |
|
|
2024
Q2 | $2.1K | Hold |
2
| – | – | ﹤0.01% | 393 |
|
|
2024
Q1 | $1.93K | Hold |
2
| – | – | ﹤0.01% | 334 |
|
|
2023
Q4 | $1.76K | Hold |
2
| – | – | ﹤0.01% | 307 |
|
|
2023
Q3 | $1.65K | Hold |
2
| – | – | ﹤0.01% | 283 |
|
|
2023
Q2 | $1.44K | Hold |
2
| – | – | ﹤0.01% | 248 |
|
|
2023
Q1 | $1.64K | Hold |
2
| – | – | ﹤0.01% | 241 |
|
|
2022
Q4 | $1.44K | Hold |
2
| – | – | ﹤0.01% | 246 |
|
|
2022
Q3 | $1.38K | Buy |
+2
| New | +$1.38K | ﹤0.01% | 238 |
|